Nucleus 3:2, 126–131; March/April 2012;
G
2012 Landes Bioscience
Chromatin signatures of active enhancers Salvatore Spicuglia1,2,* and Laurent Vanhille1,2,3,4,5 1
Inserm, UMR_S 928, TAGC; Marseille, France; 2Aix-Marseille University; Marseille, France; 3Centre d’Immunologie de Marseille-Luminy; Marseille, France; Inserm, U631; Marseille, France; 5CNRS, UMR6102; Marseille, France
4
G
ene-distal cis-regulatory sequences, such as enhancers, are key contributors of tissue-specific gene expression. In particular, enhancers can be located up to hundreds of kilobases from the promoters that they control, making their identification challenging. Thanks to the recent technological advances to map histone modifications and chromatin-associated factors genome-wide, several studies have begun to characterize chromatin signatures of active enhancers. Here, we discuss some of these results and how they provide new insights into the tissue-specific organization of enhancer repertoires.
transcription factor (TF) functions and epigenetic processes involved in the control of gene transcription.5 In particular, they offer an increasingly clear picture of the basic enhancer organizations and functions.1,2 This review focuses on the recent finding of chromatin signatures allowing the genome-wide identification of enhancer elements and the characterization of their cell-type specific activities.
© 2012 Landes Bioscience.
Genome-Wide Characterization of Enhancers
Do not distribute. Introduction
Keywords: enhancer, chromatin structure, histone modification, high throughput sequencing, ChIP-seq Submitted: 11/29/11 Revised: 12/29/11 Accepted: 01/02/11 http://dx.doi.org/10.4161/nucl.19232 *Correspondence to: Salvatore Spicuglia; Email:
[email protected] Extra View to: Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J 2011; 30:4198–210; PMID:21847099; http://dx.doi. org/10.1038/emboj.2011.295
126
Functional enhancers are cis-regulatory DNA elements that are independent of orientation and position and can act at variable distances from the transcription start site (TSS) of the genes they regulate.1,2 They are able to establish longrange interactions with the promoters of regulated genes and are key contributors of tissue-specific gene regulation.3 Recent technological advances, particularly the combination of chromatin immunoprecipitation (ChIP) with either microarrays (ChIP-on-chip) or highthroughput sequencing (ChIP-seq), and the development of refined computational tools for the analysis of large data sets, now allow us to precisely investigate the genome-wide distribution of chromatinbinding proteins and histone modifications in any sequenced genome.4 The application of this technique, and related approaches, to a variety of developmental and differentiation systems in mammals has provided global views of the cis-regulatory elements,
Nucleus
The flexible localization of enhancers with respect to the regulated genes have for a longtime impaired the global identification and characterization of enhancers at the whole genome level. In the past, isolation of enhancers have been based on laborious molecular approaches based on either chromatin structure (e.g., DNase I hypersensitivity assay) and/or transactivation activity (e.g., gene reporter assays), sometimes coupled with the analysis of noncoding sequence conservation.1,2 With the recent development of microarray-based and high throughput sequencing technologies, it is now possible to identify enhancers at the genome-wide scale (Table 1).5 The most straightforward strategy has been to adapt DNase I-based approaches genome wide.6,7,23-25 A similar method, named NA-Seq, used specific sequencing of restriction enzymes accessible regions for identifying cis-regulatory elements.8 An alternative approach is provided by the formaldehyde assisted isolation of regulatory elements (FAIRE) assay, which allows the recovery of the soluble (i.e., nucleosome-free) fraction of the chromatin.9,10 In parallel, ChIP-onchip and ChIP-seq studies have shed light
Volume 3 Issue 2
EXTRA VIEW
on the distribution of epigenetic marks and the striking correlations between the local enrichment for histone modifications and chromatin-associated factors and the presence and, possibly, the functional state, of transcriptional cis-regulatory elements.26-31 In particular, these studies have led to define chromatin signatures characteristic of discrete types of cis-regulatory regions (Table 1). In a pioneering study, the monomethylation of histone H3 lysine 4 (H3K4me1) was found to be a hallmark of promoter-distal cis-regulatory elements (i.e., enhancers) in HeLa cells.14 This signature was based on the relative abundance of H3K4me1 as compared with trimethylation (H3K4me3) at promoters and enhancers, the latter being defined as the gene-distal genomic regions bound by the transcription factor p300, a general transcriptional co-activator. The same group used a similar approach to demonstrate that histone modifications of enhancers, namely H3K4me1, reflect global cell-type-specific gene expression.32 Several studies, subsequently used these or similar criteria to characterize enhancers in various developmental and stimulatory contexts (for examples, see refs. 16–18, 33–35). Therefore, it is now possible to catalog enhancers by identifying chromatin signatures that are not, or little, associated with other functional elements, thus providing a global view of the general dynamic of enhancer’s repertoires.
Although the presence of H3K4me1 has been largely used as a “hallmark” of distal cis-regulatory elements, its systematic usage to identify enhancers genome-wide might present several caveats. On the one hand, H3K4me1 enriched regions are generally larger than the associated cisregulatory elements (for examples, see refs. 18 and 27). Consequently, it is difficult to define the exact location of the actual enhancer site(s) they contain. On the other hand, the presence of H3K4me1 per se does not strictly correlate with the functional activity of these elements.16-18,33,34 In this respect, the efficiency to accurately predict functional enhancers based solely on the H3K4me1 profiles is relatively low.14,18,35 Taking these observations into consideration, it is believed that H3K4me1 patterns rather mark a wide spectrum of enhancers associated with tissue-specific genes that become further activated or repressed in a lineage-restricted manner.
CD4+ T cells, the laboratory of Keji Zhao has actually shown that putative enhancer regions are enriched in several histone marks, including the three levels of H3K4 methylation, H3K27 acetylation (H3K27ac) and the histone variant H2A. Z.27,30 More recently, three independent studies compared the epigenetic profiles of ES cells to several differentiated tissues, and found that H3K27ac was specifically associated with active enhancers.16,17,36 Interestingly, while the class of active enhancers was found to be enriched in both H3K4me1 and H3K27ac, another class, termed “poised” enhancers (see below), was enriched in H3K4me1 only and linked to genes inactive in ES cells, but involved in orchestrating early steps in embryogenesis. Mechanistically, the presence of H3K27ac at active enhancers might reflect the recruitment of specific histone acetyl-transferases (HAT), such as p300 and CBP, which are able to acetylate H3K27 in vivo.37 As mentioned above, it has been suggested that distal regulatory elements are characterized by the presence of H3K4me1 in the absence of significant levels of H3K4me3, which in turn is associated with active gene promoters.14 However, this sharp difference between the two marks is not obvious in other studies (for examples, see refs. 27, 30, 38 and 39). In order to define more precisely the chromatin signature of active enhancers, we recently investigated the combinatorial of H3K4 methylation status in enhancer elements during the process of T lymphoid cell differentiation in the adult mouse thymus.18 Upon analyzing the dynamic of histone modifications at well-defined T-cell loci, active enhancers were found to be generally associated with the presence of both H3K4me2 and H3K4me3, while H3K4me1 was present at enhancers regardless of their functional state (Fig. 1). Interestingly, enhancer activity, as assessed by gene reporter assay, specifically correlated with the presence of H3K4me1 and H3K4me3 but not with H3K4me1 alone.18 Furthermore, gain or loss of H3K4me2/3 at distal genomic regions correlated with, respectively, the induction or the repression of associated genes during T-cell development.18 All in all, these findings strongly support the notion that distal
© 2012 Landes Bioscience. Chromatin Signatures of Active Enhancers
Do not distribute. It is clear from the studies described above that H3K4me1 might not be the only histone modification present at enhancer elements and that a more accurate definition of the chromatin signature of active enhancers is required. By analyzing a large set of histone modifications in human
Table 1. Current approaches used to map distal enhancers genome-wide Approach
Activity1
Specificity2
Examples
DNase I-seq
Open
Non
refs. 6, 7
NA-seq
Open
Non
ref. 8
FAIRE
Open
Non
refs. 9, 10
P300 (ChIP-seq)
Open
Enh. = Prom.
refs. 11–13
H3K4me1 (ChIP-seq)
Open
Enh. . Prom.
refs. 11, 14
H3K4me2 (ChIP-seq)
Open
Enh. = Prom.
ref. 15
H3K27ac (ChIP-seq)
Active
Enh. . Prom.
refs. 16, 17
H3K4me3 (ChIP-seq)
Active
Prom. . Enh.
ref. 18
Pol II (ChIP-seq)
Active
Prom. . Enh.
refs. 19–21
BRG1 (ChIP-Seq)
Active
Enh. = Prom.
ref. 22
1
Refers to whether the approach allows the discrimination between poised and active enhancers. “Open” means that the approach identifies both poised and active enhancers without discrimination. In some cases, a quantitative difference in either chromatin accessibility or the enrichment of the specified factor or histone modification might be observed between poised and active enhancers. 2 Refers to whether the approach preferentially marks enhancers (Enh. . Prom.), promoters (Prom. . Enh.) or both regions (Enh. = Prom.).
www.landesbioscience.com
Nucleus
127
© 2012 Landes Bioscience.
Figure 1. Schematic view of the epigenetic dynamics at induced genes during early T-cell differentiation. In the early CD4-CD8- double negative (DN) thymocytes, the enhancer is enriched for H3K4me1 and is found in a poised configuration. During differentiation into CD4+CD8+ double positive (DP) thymocytes, induced enhancers recruit Pol II and acquire H3K4me3. The profiles shown here are inspired of canonical loci described in reference 18.
Do not distribute.
H3K4me1 domains are enriched for lineage specific enhancers, whereas the functional activity of these regulatory regions can be assessed from the presence of additional histone modifications (Table 1). Is there a functional redundancy between the presence of H3K27ac and H3K4me3 at active enhancers? A comprehensive study mapped nine histone modifications across nine human cell types, including common lines designated by the ENCODE consortium40 and primary cell types.35 By the recurrent combination of histone marks they were able to define 15 chromatin states, from which four corresponded to distinct categories of weak (or poised) and strong (or active) enhancers.35 In agreement with the results described above, active enhancers could be defined by the co-occurrence of H3K4me1, H3K4me2, H3K27ac and, for a subset of active enhancers, the additional presence of H3K4me3 and H3K9ac.35 It will be of interest to determine whether the presence of H3K27ac and H3K4me3 marks distinct classes of active enhancers.
128
Enhancer Transcription and Pol II-Dependent Deposition of H3K4me3 What could be the functional significance of H3K4 trimethylation at enhancers? H3K4me3 is closely linked to RNApolymerase II (Pol II) recruitment and the onset of transcription initiation at gene promoters.28,41 Pol II binding at enhancers has been described at several loci42 and seems to be a common trait of distal regulatory elements,19-21 most probably associated with the setting of enhancers’ activity. Interestingly, active enhancers are specifically associated to the initiating (Serine 5 phosphorylated) form of Pol II and undergo localized transcription.19-21 It is therefore likely that, as in the case of promoter regions, H3K4 trimethylation at enhancers actually reflect their local occupancy by initiating Pol II. We have confirmed and extended these results by showing that Pol II is specifically recruited by active enhancers in differentiating T cells (Fig. 1).18 Moreover, we found that Pol II occupancy was strictly well
Nucleus
correlated with the dynamic process of H3K4me3 enrichment occurring in distal regulatory elements.18 These findings suggest the possibility that H3K4me3 may be present in enhancer regions as a consequence of local Pol II occupancy. Strikingly, distal genomic regions selected by the co-occurrence of CBP (a p300 homolog), H3K4me1, H3K4me3 and Pol II are more frequently associated with tissue-specific genes than a selection based on CBP and H3K4me1 only.21 Poised Enhancers and Priming As mentioned above, not all H3K4me1marked enhancers are actively engaged in regulating transcription in a given cell type. Some H3K4me1-marked enhancers modulate transcription in response to differentiation cues or other cellular stimuli and are thus considered poised.16-18,33,34,43,44 It is possible that H3K4me1 marking of developmentally regulated enhancers before transcriptional activation may constitute (or reflect) an epigenetic priming mechanism.45 In this
Volume 3 Issue 2
scenario, poised enhancers might be preassembled in the form of an inactive nucleoprotein complex prior to activation. A striking example is provided by the inflammatory response during which the intersection of lineage determining TFs, such as PU.1 at macrophage enhancers, set the stage for the activity of stimulusactivated TFs like NF-kb, AP-1 and interferon regulatory factors (IRFs), therefore explaining cell-type specificity in inflammatory responses.43,46 Interestingly, PU.1 binds to most macrophage enhancers and is both necessary and sufficient to establish cell-type specific enhancers.43,44,46 Similarly, the C/EBPβ TF binds a large number of enhancers before induction of adipocyte differentiation and is required for their establishment.25 Subsequently, a subset of these regulatory elements remains accessible and is eventually occupied by more restricted TFs.25 Thus, simple combinations of lineage-determining and stage-specific TFs can specify the genomic sites ultimately responsible for both cell identity and cell-type-specific responses to diverse developmental and stimulatory signals (Fig. 2). Whether poised enhancers are marked by repressive histone marks is not yet clear. On the one hand, some studies have found that CpGs within developmentallyregulated38 or glucocorticoid-induced47 enhancers are methylated prior to activation and undergo cell-type specific DNA demethylation. On the other hand, a subset of poised enhancers in ES cells contains H3K4me1 along with the repressive histone modification H3K27me3 and, to a lesser extent, with H3K9me3.17,36 However, this do not seems to be a general rule. In our study, we found very little correlation between the presence of H3K27me3 or H3K9me2 at H3K4me1poised enhancers.18 Similarly, in the study by Ernst et al. no correlation was found between poised enhancers and the presence of H3K27me3.35 Thus, repressive histone or DNA methylation marks are more likely to be specific to a subset of poised enhancers required during development and/or cell differentiation. Apart from repressive histone modifications, nucleosomes present itself a major barrier for the access of TFs to their target sites in vivo. Thus, positioning of
enhancer nucleosomes might be regulated to allow for binding of lineage-specific TFs during development and/or cell activation. Recent studies have suggested that the activation of transcription is indeed correlated with the reorganization of nucleosomes at enhancer elements.15,48-51 In this respect, master regulators are thought to initially bind the enhancers and remodel nucleosome positioning in order to allow other TFs to gain access to their target sequences
(Fig. 2). This process is, at least, partially mediated by the recruitment of ATPdependent remodeling factors such as BRG1, a subunit of the SWI/SNF remodeling complex.52 Interestingly, distal BRG1 binding is well correlated with the regulation of gene expression and represent a useful marker for identifying distal cis-regulatory regions.22,49 For instance, during erythroid differentiation, binding of TAL1 to enhancers is facilitated by GATA1 recruitment of BRG1 and
© 2012 Landes Bioscience. Do not distribute.
www.landesbioscience.com
Figure 2. Chromatin dynamics at tissue-specific enhancers during cell differentiation. In early precursors or non-relevant lineages, the enhancer region is cover by nucleosomes and often associated to repressive marks, such as H3K27me3 or DNA methylation. During differentiation, lineage-specific TFs (also called master regulators or enhancer organizers) bind to the majority of the tissue-specific enhancer repertoire. These enhancers are nucleosome free regions and enriched for H3K4me1, but are generally in a poised state. Subsequently, upon cell differentiation and/or external stimuli, induced or activated TFs binds to some of the accessible enhancers in order to fine-tune gene expression. Active enhancers are now associated with additional cofactors such as BRG1, p300 and Pol II and correlate with further nucleosome remodeling, acquisition of additional histone modifications, such as H3K27ac and H3K4me3, and local transcription.
Nucleus
129
subsequent remodeling of enhancer associated nucleosomes.49 Conclusion The recent technological advances to map histone modifications and chromatinassociated factors genome-wide have provided new and exciting insights into the tissue-specific organization of enhancer repertoires. The general view that comes out from these studies is summarized in Figure 2. The analysis of chromatin signatures of enhancers in different cell types has provided direct evidence that the activity of this elements show very little overlap across different tissues, suggesting that a sizable fraction of the enhancer References 1.
Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet 2011; 12:283-93; PMID:21358745; http://dx.doi.org/10.1038/nrg2957 2. Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011; 144:327-39; PMID:21295696; http://dx.doi.org/10. 1016/j.cell.2011.01.024 3. Natoli G. Maintaining cell identity through global control of genomic organization. Immunity 2010; 33: 12-24; PMID:20643336; http://dx.doi.org/10.1016/j. immuni.2010.07.006 4. Kidder BL, Hu G, Zhao K. ChIP-Seq: technical considerations for obtaining high-quality data. Nat Immunol 2011; 12:918-22; PMID:21934668; http:// dx.doi.org/10.1038/ni.2117 5. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011; 12:7-18; PMID:21116306; http://dx.doi.org/10.1038/nrg2905 6. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 2008; 132:311-22; PMID:18243105; http://dx. doi.org/10.1016/j.cell.2007.12.014 7. Crawford GE, Holt IE, Whittle J, Webb BD, Tai D, Davis S, et al. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 2006; 16:123-31; PMID:16344561; http://dx.doi.org/10.1101/gr.4074106 8. Gargiulo G, Levy S, Bucci G, Romanenghi M, Fornasari L, Beeson KY, et al. NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation. Dev Cell 2009; 16: 466-81; PMID:19289091; http://dx.doi.org/10.1016/ j.devcel.2009.02.002 9. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res 2007; 17:877-85; PMID: 17179217; http://dx.doi.org/10.1101/gr.5533506 10. Eeckhoute J, Lupien M, Meyer CA, Verzi MP, Shivdasani RA, Liu XS, et al. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 2009; 19:37280; PMID:19129543; http://dx.doi.org/10.1101/gr. 084582.108
repertoire may be cell-type specific. In other words, of all the possible regulatory regions in the genome, only a small subset is selected for activation in a given cell type, which is probably essential for cell differentiation. Discriminating between poised and active enhancers will be crucial to unravel transcriptional regulatory networks during normal development and disease. Furthermore, given the potential impact of genomic alterations at distal regulatory regions in cancer and disease,53 it will be critical to dispose in the near future of a comprehensive catalog of all enhancer elements potentially actives in every human cell type and their pathological counterparts. The current efforts by the 11. Heintzman ND, Ren B. Finding distal regulatory elements in the human genome. Curr Opin Genet Dev 2009; 19:541-9; PMID:19854636; http://dx.doi.org/ 10.1016/j.gde.2009.09.006 12. Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, Holt A, et al. ChIP-Seq identification of weakly conserved heart enhancers. Nat Genet 2010; 42:806-10; PMID:20729851; http://dx.doi.org/10.1038/ng.650 13. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457:854-8; PMID: 19212405; http://dx.doi.org/10.1038/nature07730 14. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39:311-8; PMID:17277777; http://dx.doi.org/10.1038/ng1966 15. He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, et al. Nucleosome dynamics define transcriptional enhancers. Nat Genet 2010; 42:343-7; PMID: 20208536; http://dx.doi.org/10.1038/ng.545 16. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010; 107: 21931-6; PMID:21106759; http://dx.doi.org/10.1073/ pnas.1016071107 17. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011; 470:279-83; PMID:21160473; http:// dx.doi.org/10.1038/nature09692 18. Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, et al. H3K4 trimethylation provides an epigenetic signature of active enhancers. EMBO J 2011; 30:4198-210; PMID: 21847099; http://dx.doi.org/10.1038/emboj.2011.295 19. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010; 465: 182-7; PMID:20393465; http://dx.doi.org/10.1038/ nature09033 20. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 2010; 8:e1000384; PMID:20485488; http://dx.doi. org/10.1371/journal.pbio.1000384
International Human Epigenome Consortium (IHEC; www.ihec-epigenomes. org) and the ENCODE project (www. genome.gov/encode) to coordinate largescale mapping and characterization of the epigenome will be essential to achieve this goal. Acknowledgments
We thank Dr Jean Imbert for critical reading of this manuscript. Research in SS lab is supported by recurrent funding from the Inserm and Aix-Marseille University, and by a specific grant from the European Union’s Seventh Framework Program (FP7/2007–2013) under grant agreement n° 282510-BLUEPRINT. L.V. is supported by the FP7 grant. 21. Koch F, Fenouil R, Gut M, Cauchy P, Albert TK, Zacarias-Cabeza J, et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol 2011; 18:956-63; PMID:21765417; http://dx.doi.org/10.1038/nsmb.2085 22. De S, Wurster AL, Precht P, Wood WH, 3rd, Becker KG, Pazin MJ. Dynamic BRG1 recruitment during T helper differentiation and activation reveals distal regulatory elements. Mol Cell Biol 2011; 31:1512-27; PMID: 21262765; http://dx.doi.org/10.1128/MCB.00920-10 23. Crawford GE, Davis S, Scacheri PC, Renaud G, Halawi MJ, Erdos MR, et al. DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat Methods 2006; 3:503-9; PMID: 16791207; http://dx.doi.org/10.1038/nmeth888 24. Sabo PJ, Kuehn MS, Thurman R, Johnson BE, Johnson EM, Cao H, et al. Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays. Nat Methods 2006; 3:511-8; PMID: 16791208; http://dx.doi.org/10.1038/nmeth890 25. Siersbæk R, Nielsen R, John S, Sung MH, Baek S, Loft A, et al. Extensive chromatin remodelling and establishment of transcription factor ‘hotspots’ during early adipogenesis. EMBO J 2011; 30:1459-72; PMID:21427703; http://dx.doi.org/10.1038/emboj. 2011.65 26. Mendenhall EM, Bernstein BE. Chromatin state maps: new technologies, new insights. Curr Opin Genet Dev 2008; 18:109-15; PMID:18339538; http://dx.doi.org/ 10.1016/j.gde.2008.01.010 27. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-37; PMID:17512414; http://dx.doi.org/10. 1016/j.cell.2007.05.009 28. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007; 130:77-88; PMID:17632057; http://dx.doi.org/10. 1016/j.cell.2007.05.042 29. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448:553-60; PMID:17603471; http:// dx.doi.org/10.1038/nature06008
© 2012 Landes Bioscience. Do not distribute.
130
Nucleus
Volume 3 Issue 2
30. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40:897-903; PMID:18552846; http://dx.doi.org/10.1038/ng.154 31. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-26; PMID:16630819; http://dx.doi.org/10.1016/j.cell.2006.02.041 32. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459:108-12; PMID: 19295514; http://dx.doi.org/10.1038/nature07829 33. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009; 4:80-93; PMID:19128795; http://dx.doi.org/ 10.1016/j.stem.2008.11.011 34. Mercer EM, Lin YC, Benner C, Jhunjhunwala S, Dutkowski J, Flores M, et al. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 2011; 35:413-25; PMID:21903424; http:// dx.doi.org/10.1016/j.immuni.2011.06.013 35. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473:43-9; PMID:21441907; http://dx. doi.org/10.1038/nature09906 36. Zentner GE, Tesar PJ, Scacheri PC. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res 2011; 21:1273-83; PMID:21632746; http://dx.doi.org/10. 1101/gr.122382.111 37. Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE, et al. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 2011; 30:249-62; PMID:21131905; http://dx.doi.org/10.1038/emboj. 2010.318 38. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, et al. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 2009; 19: 1165-74; PMID:19494038; http://dx.doi.org/10.1101/ gr.091470.109
39. Robertson AG, Bilenky M, Tam A, Zhao Y, Zeng T, Thiessen N, et al. Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. Genome Res 2008; 18:1906-17; PMID:18787082; http://dx.doi.org/10. 1101/gr.078519.108 40. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, et al, ENCODE Project Consortium, NISC Comparative Sequencing Program, Baylor College of Medicine Human Genome Sequencing Center, Washington University Genome Sequencing Center, Broad Institute & Children’s Hospital Oakland Research Institute. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447:799-816; PMID:17571346; http://dx.doi.org/10. 1038/nature05874 41. Selth LA, Sigurdsson S, Svejstrup JQ. Transcript Elongation by RNA Polymerase II. Annu Rev Biochem 2010; 79:271-93; PMID:20367031; http://dx.doi.org/ 10.1146/annurev.biochem.78.062807.091425 42. Koch F, Jourquin F, Ferrier P, Andrau JC. Genomewide RNA polymerase II: not genes only! Trends Biochem Sci 2008; 33:265-73; PMID:18467100; http://dx.doi.org/10.1016/j.tibs.2008.04.006 43. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010; 32:317-28; PMID:20206554; http://dx.doi.org/10. 1016/j.immuni.2010.02.008 44. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineagedetermining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010; 38:576-89; PMID:20513432; http:// dx.doi.org/10.1016/j.molcel.2010.05.004 45. Natoli G, Ghisletti S, Barozzi I. The genomic landscapes of inflammation. Genes Dev 2011; 25:101-6; PMID: 21245163; http://dx.doi.org/10.1101/gad.2018811 46. Jin F, Li Y, Ren B, Natarajan RPU. PU.1 and C/EBP (alpha) synergistically program distinct response to NFkappaB activation through establishing monocyte specific enhancers. Proc Natl Acad Sci U S A 2011; 108:5290-5; PMID:21402921; http://dx.doi.org/10. 1073/pnas.1017214108
47. Wiench M, John S, Baek S, Johnson TA, Sung MH, Escobar T, et al. DNA methylation status predicts cell type-specific enhancer activity. EMBO J 2011; 30: 3028-39; PMID:21701563; http://dx.doi.org/10.1038/ emboj.2011.210 48. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, Wang Z, et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008; 132:887-98; PMID:18329373; http://dx.doi.org/10. 1016/j.cell.2008.02.022 49. Hu G, Schones DE, Cui K, Ybarra R, Northrup D, Tang Q, et al. Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res 2011; 21:1650-8; PMID: 21795385; http://dx.doi.org/10.1101/gr.121145.111 50. Andreu-Vieyra C, Lai J, Berman BP, Frenkel B, Jia L, Jones PA, et al. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Mol Cell Biol 2011; 31:4648-62; PMID:21969603; http://dx.doi.org/10. 1128/MCB.05934-11 51. Hoffman BG, Robertson G, Zavaglia B, Beach M, Cullum R, Lee S, et al. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res 2010; 20:1037-51; PMID:20551221; http://dx.doi.org/10.1101/gr.104356.109 52. Eberharter A, Becker PB. ATP-dependent nucleosome remodelling: factors and functions. J Cell Sci 2004; 117:3707-11; PMID:15286171; http://dx.doi.org/10. 1242/jcs.01175 53. Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-acting enhancers. Nature 2009; 461: 199-205; PMID:19741700; http://dx.doi.org/10.1038/ nature08451
© 2012 Landes Bioscience. Do not distribute.
www.landesbioscience.com
Nucleus
131
